Financial Statements
Income Statement
Quarterly Data
The income statement (statement of earnings) reports on the performance of Regeneron Pharmaceuticals Inc., the result of its operating activities.
Balance Sheet: Assets
Quarterly Data
The assets reports major classes and amounts of resources owned or controlled by Regeneron Pharmaceuticals Inc..
Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
Cash Flow Statement
Quarterly Data
The cash flow statement provides information about Regeneron Pharmaceuticals Inc. cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on Regeneron Pharmaceuticals Inc. balance sheet.
Common-Size Financial Statements
Common-Size Income Statement
Quarterly Data
Income statement components (revenues and expenses) shown as percentage of total sales.
Common-Size Balance Sheet: Assets
Quarterly Data
Assets components shown as percentage of total assets.
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
Analysis of Financial Ratios
Analysis of Profitability Ratios
Quarterly Data
Measures the income of Regeneron Pharmaceuticals Inc. relative to its revenues and invested capital.
Analysis of Liquidity Ratios
Quarterly Data
Measures the adequacy of a Regeneron Pharmaceuticals Inc. cash resources to meet its near-term cash obligations.
Analysis of Solvency Ratios
Quarterly Data
Examines Regeneron Pharmaceuticals Inc. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Analysis of Short-term (Operating) Activity Ratios
Quarterly Data
Evaluates revenues and output generated by the Regeneron Pharmaceuticals Inc. assets. Operating performance ratios describe the relationship between the Regeneron Pharmaceuticals Inc. level of operations and the assets needed to sustain operating activities.
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Regeneron Pharmaceuticals Inc. generates revenues from its investments in fixed or total assets.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data
An approach to decomposing Regeneron Pharmaceuticals Inc. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Relative Valuation
Common Stock Valuation Ratios
Quarterly Data
Relative valuation technique determine the value of Regeneron Pharmaceuticals Inc. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.